Guy Heynen

Adipopharma is a French biotech company that focuses on developing treatments for insulin resistance, type 2 diabetes, and related conditions.

AbolerIS Pharma develops therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune, and degenerative diseases. The company was founded by Carole Guillonneau, Ignacio Anegon and François-Xavier Hubert and is headquartered in Nantes, France.

NeuVasQ Biotechnologies SA develops pharmaceutical products to treat neurological disorders by repairing neurovascular function. The company is based in Gosselies, Belgium. The Belgian company was founded in 2021 by Benoit Vanhollebeke.

DIM3 SA develops decision support application software and medical devices. The firm offers Scorso, an app for the screening and follow-up of disease-related malnutrition; Nutrow, a decision support software for an optimization of clinical nutrition; and Biocorder, a connected clinical mobile assistant. The company was founded by Jean Claude Havaux on September 23, 2004 and is headquartered in Liege, Belgium.

ChromaCure SA develops therapeutic molecules to fight against cancer. The company is based in Charleroi, Belgium. The Belgian company was founded in 2018 by Cedric Blanpain, who has been the CEO since 2018.

ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium.